These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37229916)

  • 1. The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders.
    Mir HD; Giorgini G; Di Marzo V
    Psychoneuroendocrinology; 2023 Aug; 154():106295. PubMed ID: 37229916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the Gut Microbiome, Immunity, and Neuroinflammation in the Pathophysiology of Eating Disorders.
    Butler MJ; Perrini AA; Eckel LA
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33546416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review on the role of microbiota in the pathogenesis and treatment of eating disorders.
    Carbone EA; D'Amato P; Vicchio G; De Fazio P; Segura-Garcia C
    Eur Psychiatry; 2020 Dec; 64(1):e2. PubMed ID: 33416044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Endocannabinoidome in Human and Mouse Atherosclerosis.
    Piscitelli F; Silvestri C
    Curr Pharm Des; 2019; 25(29):3147-3164. PubMed ID: 31448709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
.
    Di Marzo V
    Dialogues Clin Neurosci; 2020 Sep; 22(3):259-269. PubMed ID: 33162769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the intestinal microbiota in eating disorders - bulimia nervosa and binge eating disorder.
    Herman A; Bajaka A
    Psychiatry Res; 2021 Jun; 300():113923. PubMed ID: 33857846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders.
    Smitka K; Prochazkova P; Roubalova R; Dvorak J; Papezova H; Hill M; Pokorny J; Kittnar O; Bilej M; Tlaskalova-Hogenova H
    Front Endocrinol (Lausanne); 2021; 12():613983. PubMed ID: 33953692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.
    Manca C; Boubertakh B; Leblanc N; Deschênes T; Lacroix S; Martin C; Houde A; Veilleux A; Flamand N; Muccioli GG; Raymond F; Cani PD; Di Marzo V; Silvestri C
    J Lipid Res; 2020 Jan; 61(1):70-85. PubMed ID: 31690638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice.
    Lacroix S; Pechereau F; Leblanc N; Boubertakh B; Houde A; Martin C; Flamand N; Silvestri C; Raymond F; Di Marzo V; Veilleux A
    mSystems; 2019 Dec; 4(6):. PubMed ID: 31848310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome.
    Forteza F; Giorgini G; Raymond F
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Gut Microbiota in Anorexia Nervosa in Children and Adults-Systematic Review.
    Anton-Păduraru DT; Trofin F; Nastase EV; Miftode RS; Miftode IL; Trandafirescu MF; Cojocaru E; Țarcă E; Mindru DE; Dorneanu OS
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary food patterns as determinants of the gut microbiome-endocannabinoidome axis in humans.
    Castonguay-Paradis S; Perron J; Flamand N; Lamarche B; Raymond F; Di Marzo V; Veilleux A
    Sci Rep; 2023 Sep; 13(1):15702. PubMed ID: 37735572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and correlates of bulimia nervosa, binge-eating disorder, and anorexia nervosa: The Saudi National Mental Health Survey.
    AlHadi AN; Almeharish A; Bilal L; Al-Habeeb A; Al-Subaie A; Naseem MT; Altwaijri YA
    Int J Eat Disord; 2022 Nov; 55(11):1541-1552. PubMed ID: 35932093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota metabolites mediate the interplay between childhood maltreatment and psychopathology in patients with eating disorders.
    Castellini G; Cassioli E; Vitali F; Rossi E; Dani C; Melani G; Flaccomio D; D'Andria M; Mejia Monroy M; Galli A; Cavalieri D; Ricca V; Bartolucci GL; De Filippo C
    Sci Rep; 2023 Jul; 13(1):11753. PubMed ID: 37474544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome.
    Shen M; Manca C; Suriano F; Nallabelli N; Pechereau F; Allam-Ndoul B; Iannotti FA; Flamand N; Veilleux A; Cani PD; Silvestri C; Di Marzo V
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metacognitive beliefs across eating disorders and eating behaviours: A systematic review.
    Palmieri S; Mansueto G; Ruggiero GM; Caselli G; Sassaroli S; Spada MM
    Clin Psychol Psychother; 2021 Sep; 28(5):1254-1265. PubMed ID: 33606916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiome, endocannabinoids and metabolic disorders.
    Iannotti FA; Di Marzo V
    J Endocrinol; 2021 Feb; 248(2):R83-R97. PubMed ID: 33337346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of brain endocannabinoidome signaling in germ-free mice.
    Manca C; Shen M; Boubertakh B; Martin C; Flamand N; Silvestri C; Di Marzo V
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158786. PubMed ID: 32795503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central coherence and set-shifting between nonunderweight eating disorders and anorexia nervosa: A systematic review and meta-analysis.
    Keegan E; Tchanturia K; Wade TD
    Int J Eat Disord; 2021 Mar; 54(3):229-243. PubMed ID: 33305366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Microbiota Imbalance in Anxiety and Eating Disorders: Probiotics as Novel Therapeutic Approaches.
    Navarro-Tapia E; Almeida-Toledano L; Sebastiani G; Serra-Delgado M; García-Algar Ó; Andreu-Fernández V
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.